Featured Research

from universities, journals, and other organizations

Malaria study suggests drugs should target female parasites

Date:
November 28, 2012
Source:
University of Glasgow
Summary:
Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease.

Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease.

Research into malaria parasites -- which exist in male and female forms, and mate to spread the disease -- suggests that treatments would be more likely to succeed if designed to target female forms of the parasite.

Scientists found that male parasites can adapt to new surroundings faster than the females. When malaria infects the bloodstream after a mosquito bite, the male parasites are better able to react quickly to repeated attacks by the immune system and so are likely to be harder to treat with drugs and vaccines.

Researchers at the University of Edinburgh, who took part in the study, examined the genetic fingerprint of various species of malaria parasites at different stages in their life cycles. They found that genes associated with male parasites tended to evolve faster over time than those of females.

Targeting the females would be more likely to succeed in killing the infection in the long term and would prevent the parasites from breeding and spreading.

The research, carried out in collaboration with the University of Glasgow, Leiden University Medical Centre, Netherlands, and the Institute of Biochemistry and Biophysics in Warsaw of the Polish Academy of Sciences, was published in the journal Evolution, Medicine and Public Health. It was supported by the Wellcome Trust, the European Union, the Polish Ministry of Science and the Foundation for Polish Science.

Dr Sarah Reece of the University of Edinburgh's School of Biological Sciences, who co-led the study, said: "Malaria is notorious for evolving to evade treatment -- it is crucial that drugs and vaccines are designed to target the slower, female, form of the parasite."


Story Source:

The above story is based on materials provided by University of Glasgow. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. E. Reece, S. M. Khan, A. P. Waters, C. J. Janse, S. Kaczanowski. Why are male malaria parasites in such a rush? Sex-specific evolution and host-parasite interactions. Evolution, Medicine, and Public Health, 2012; DOI: 10.1093/emph/eos003

Cite This Page:

University of Glasgow. "Malaria study suggests drugs should target female parasites." ScienceDaily. ScienceDaily, 28 November 2012. <www.sciencedaily.com/releases/2012/11/121128093915.htm>.
University of Glasgow. (2012, November 28). Malaria study suggests drugs should target female parasites. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2012/11/121128093915.htm
University of Glasgow. "Malaria study suggests drugs should target female parasites." ScienceDaily. www.sciencedaily.com/releases/2012/11/121128093915.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins